ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 011,83
0,07%
Dow Jones
44 470,41
0,38%
DAX
21 940,82
0,03%
Brent Oil
76,635
0,94%
Bitcoin
98 045,15
0,58%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Achieve Life Sciences Inc (ACHV) Cours

Achieve Life Sciences Inc

Achieve Life Sciences Inc (ACHV)

NASDAQ
3,53
0,48
(15,74%)
Fermé 11 Février 10:00PM
Retardé de 15 minutes
3,53
0,00
( 0,00% )
Avant marché: 10:03AM
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
3,53
Prix Achat
3,54
Prix Vente
3,85
Volume échangé
6
0,00 Fourchette du Jour 0,00
2,84 Plage de 52 semaines 5,59
Cap du marché
121,397M
Clôture Veille
3,53
Ouverture
-
Dernière Transaction
6
@
3.53
Dernière heure de transaction
10:18:38
Volume financier
-
VWAP
-
Volume moyen (3 m)
211 802
Actions en circulation
34 389 946
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-4,07
Bénéfice par action (BPA)
-0,87
Chiffre d'affairess
-
Bénéfice net
-29,82M

À propos de Achieve Life Sciences Inc

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. ... Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the global smoking health epidemic through the development and commercialization of cytisinicline. Show more

Secteur
In Vitro,in Vivo Diagnostics
Industrie
Drugs-health R&d/testing Labs
Site Web
www.achievelifesciences.com
Siège social
Wilmington, Delaware, USA
Fondé
1991
Achieve Life Sciences Inc est coté dans le secteur In Vitro,in Vivo Diagnostics de la NASDAQ avec le ticker ACHV. Le dernier cours de clôture d'Achieve Life Sciences était de US$3,53. Au cours de la dernière année, les actions de Achieve Life Sciences ont été négociées dans une fourchette de prix de US$ 2,84 à US$ 5,59.

Achieve Life Sciences compte actuellement 34 389 946 actions en circulation. La capitalisation boursière d'Achieve Life Sciences est de US$121,40 million. Achieve Life Sciences a un ratio cours/bénéfice (ratio PE) de -4.07.

ACHV Dernières nouvelles

Plus de nouvelles

Form 8-K - Current report

il y a 14 heures
Edgar (US Regulatory)

Achieve Life Sciences Announces Positive Outcome of Second Data Safety Monitoring Committee Review for the ORCA-OL Clinical Trial

No Safety Concerns Identified by DSMC in the ORCA-OL Long-Term Exposure Trial Achieve Reiterates Planned Cytisinicline NDA Submission in Q2 2025 SEATTLE and VANCOUVER, British Columbia, Feb...

il y a 21 heures
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

30 Janvier 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

30 Janvier 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

30 Janvier 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

14 Janvier 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

14 Janvier 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

14 Janvier 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

14 Janvier 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

14 Janvier 2025
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.288.615384615383.253.543.022724743.34857407CS
40.185.373134328363.353.542.842574863.17529009CS
12-0.81-18.663594474.344.6552.842118023.59010377CS
26-0.82-18.85057471264.355.312.841503103.99802019CS
52-0.96-21.38084632524.495.592.841647644.40089222CS
156-4.35-55.20304568537.8810.321108624.88490527CS
2603.0074575.4688097970.522623.240.2257444237072.65234936CS

ACHV - Frequently Asked Questions (FAQ)

What is the current Achieve Life Sciences share price?
The current share price of Achieve Life Sciences is US$ 3,53
How many Achieve Life Sciences shares are in issue?
Achieve Life Sciences has 34 389 946 shares in issue
What is the market cap of Achieve Life Sciences?
The market capitalisation of Achieve Life Sciences is USD 121,4M
What is the 1 year trading range for Achieve Life Sciences share price?
Achieve Life Sciences has traded in the range of US$ 2,84 to US$ 5,59 during the past year
What is the PE ratio of Achieve Life Sciences?
The price to earnings ratio of Achieve Life Sciences is -4,07
What is the reporting currency for Achieve Life Sciences?
Achieve Life Sciences reports financial results in USD
What is the latest annual profit for Achieve Life Sciences?
The latest annual profit of Achieve Life Sciences is USD -29,82M
What is the registered address of Achieve Life Sciences?
The registered address for Achieve Life Sciences is 251 LITTLE FALLS DRIVE, NEW CASTLE, WILMINGTON, DELAWARE, 19808
What is the Achieve Life Sciences website address?
The website address for Achieve Life Sciences is www.achievelifesciences.com
Which industry sector does Achieve Life Sciences operate in?
Achieve Life Sciences operates in the DRUGS-HEALTH R&D/TESTING LABS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
OCEAOcean Biomedical Inc
US$ 0,2669
(80,34%)
49,75M
VSTEVast Renewable Ltd
US$ 1,13
(63,77%)
12,62M
NOEMCO2 Energy Transition Corporation
US$ 15,76
(59,68%)
4
BBGIBeasley Broadcast Group Inc
US$ 12,48
(59,18%)
4
BSBKBogota Financial Corporation
US$ 12,29
(55,18%)
9
AIRJAirJoule Technologies Corporation
US$ 5,21
(-41,00%)
1
PRAAPRA Group Inc
US$ 14,01
(-39,69%)
7
CFSBCFSB Bancorp Inc
US$ 5,00
(-36,06%)
223
FLNCFluence Energy Inc
US$ 8,40
(-35,73%)
272,43k
SLNGStabilis Solutions Inc
US$ 5,12
(-33,16%)
5
CYNCYNGN Inc
US$ 0,2675
(44,83%)
109,63M
OCEAOcean Biomedical Inc
US$ 0,2677
(80,88%)
49,77M
BHATBlue Hat Interactive Entertainment Technology
US$ 0,0877
(27,10%)
24,9M
CLEUChina Liberal Education Holdings Ltd
US$ 0,1297
(19,54%)
23,61M
VSTEVast Renewable Ltd
US$ 1,13
(63,77%)
12,65M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
ACHV
Achieve Life Sciences
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces